Podiatrists in Bradenton, FL Accepting Medicare

42 Podiatrists found. Showing 41 - 42

Cortez Foot & Ankle Specialists, Pa Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 315 75th St W, Bradenton, FL 34209 Phone: 941-758-8818

Dr. Megan Sandora Saltzman, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1611 53rd Ave W, Bradenton, FL 34207 Phone: 941-753-9599    Fax: 941-755-0261

News Archive

Reduced expression of TBX15 in tumor tissue represents a prognostic biomarker for HCC patients

The cover for issue 52 of Oncotarget features Figure 1, "Volcano plots of DNA methylation in tumor tissues compared with nontumor tissue," published in "Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma" by Morine, et al. which reported that the authors conducted a genome-wide analysis of DNA methylation of the tumor and non-tumor tissue of 15 patients with Hepatocellular carcinoma (HCC), and revealed TBX15 was the most hypermethylated gene of the tumor.

Research investigates why medical errors occur in emergency department

Medical errors are estimated to cause 250,000 deaths per year in the US. Previously, research on admitted patients suggested that errors are due to the way doctors process the data they have about patients - in other words, doctors have the right information, but might not act on it in the best way.

Study shows chronic exposure to cadmium may cause liver disease

People with higher levels of cadmium in their urine — evidence of chronic exposure to the heavy metal found in industrial emissions and tobacco smoke — appear to be nearly 3.5 times more likely to die of liver disease than those with lower levels, according to a study by Johns Hopkins scientists.

Cryosurgery: Primary treatment option for prostate cancer

After years of innovation and intensive research, a team of Binghamton University (BU) researchers working with Cell Preservation Services, Inc., Owego, NY has broken extraordinary new ground in the recognition of cryosurgery as a primary treatment option for prostate cancer.

Australia's Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3(current)